KMC current clinical trials:
- Non-Alcoholic Steatohepatitis (NASH)
The purpose of this study is to determine whether Cenicriviroc (CVC) is safe and effective in the treatment of non-alcoholic steatohepatitis (NASH) in adults with liver fibrosis.
Only 300 sites in the entire world are currently conducting this trial. Dr. Challa and KMC are honored to be participating.
For more information regarding the NASH clinical trial, please contact Susie at 785-354-8518.